Amgen Boosts its Oncology Pipeline with US$1.16 B Acquisition of Micromet
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 2 (Table of Contents)
Published: 13 Feb-2012
DOI: 10.3833/pdr.v2012.i2.1681 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its oncology franchise, Amgen has made an offer to acquire Micromet for US$11 per share in cash in a deal that values the company at approximately US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS